Trial Profile
Antiplatelet efficacy of P2Y12 inhibitors - prasugrel, ticagrelor, clopidogrel in patients treated with mild therapeutic hypothermia after cardiac arrest due to acute myocardial infarction
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Apr 2017
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Prasugrel (Primary) ; Ticagrelor (Primary)
- Indications Heart arrest; Myocardial infarction
- Focus Therapeutic Use
- 08 Apr 2017 New trial record